Sonam Mittal

Dr. Sonam Mittal


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2020 in Cancers
Verified
Journal Article
Open access
PDF file
SMSonam Mittal
Sonam Mittal
PGPrachi Gupta
Prachi Gupta
PCPradeep Chaluvally-Raghavan
Pradeep Chaluvally-Raghavan
SPSunila Pradeep
Sunila Pradeep
The development of effective therapies for cancer treatment requires a better understanding of the tumor extracellular environment and a dynamic interaction between tumor cells, the cells of the immune system, and the tumor stroma. Increasing evidence suggests that extracellular vesicles play an important role in this interaction. Extracellular vesicles are nanometer-sized membrane-bound vesicles secreted by various types of cells that facilitate intracellular communication by transferring proteins, various lipids, and nucleic acids, especially miRNAs, between cells. Extracellular vesicles play discrete roles in the immune regulatory functions, such as antigen presentation, and activation or suppression of immune cells. Achieving therapeutic intervention through targeting of extracellular vesicles is a crucial area of research now. Thus, a deeper knowledge of exosome biology and the molecular mechanism of immune regulation is likely to provide significant insight into therapeutic intervention utilizing extracellular vesicles to combat this dreadful disease. This review describes the recent updates on immune regulation by extracellular vesicles in cancer progression and possible use in cancer therapy.

25 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Sudhir KumarSudhir Kumar
Sudhir Kumar
SMSonam Mittal
Sonam Mittal
PGPrachi Gupta
Prachi Gupta
MSMona Singh
Mona Singh
PCPradeep Chaluvally-Raghavan
Pradeep Chaluvally-Raghavan
SPSunila Pradeep
Sunila Pradeep
The interaction between tumor cells and macrophages in the tumor microenvironment plays an essential role in metabolic changes in macrophages and reprograms them towards a pro-tumorigenic phenotype. Increasing evidence indicates that macrophage metabolism is a highly complex process and may not be as simple as previously thought. Pro-inflammatory stimuli switch macrophages towards an M1-like phenotype and rely mainly on aerobic glycolysis and fatty acid synthesis, whereas anti-inflammatory stimuli switch macrophages towards an M2-like phenotype. M2-like macrophages depend more on oxidative phosphorylation (OXPHOS) and fatty acid oxidation. However, this metabolically reprogrammed phenotypic switch in macrophages remained a mystery for a while. Therefore, through this review, we tend to describe how macrophage immunometabolism determines macrophage phenotypes and functions in tumor microenvironments (TMEs). Furthermore, we have discussed how metabolic reprogramming in TAM can be used for therapeutic intervention and drug resistance in ovarian cancer.

15 February 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Deepak ParasharDeepak Parashar
Deepak Parashar
AGANJALI GEETHADEVI
ANJALI GEETHADEVI
SMSonam Mittal
Sonam Mittal
LMLindsey A. McAlarnen
Lindsey A. McAlarnen
JGJasmine George
Jasmine George
PCPradeep Chaluvally-Raghavan
Pradeep Chaluvally-Raghavan
Ovarian cancer is the most lethal gynecological malignancy among women worldwide and is characterized by aggressiveness, cancer stemness, and frequent relapse due to resistance to platinum-based therapy. Ovarian cancer cells metastasize through ascites fluid as 3D spheroids which are more resistant to apoptosis and chemotherapeutic agents. However, the precise mechanism as an oncogenic addiction that makes 3D spheroids resistant to apoptosis and chemotherapeutic agents is not understood. To study the signaling addiction mechanism that occurs during cancer progression in patients, we developed an endometrioid subtype ovarian cancer cell line named ‘MCW-OV-SL-3’ from the ovary of a 70-year-old patient with stage 1A endometrioid adenocarcinoma of the ovary. We found that the cell line MCW-OV-SL-3 exhibits interstitial duplication of 1q (q21–q42), where this duplication resulted in high expression of the PIK3C2B gene and aberrant activation of PI3K-AKT-ERK signaling. Using short tandem repeat (STR) analysis, we demonstrated that the cell line exhibits a unique genetic identity compared to existing ovarian cancer cell lines. Notably, the MCW-OV-SL-3 cell line was able to form 3D spheroids spontaneously, which is an inherent property of tumor cells when plated on cell culture dishes. Importantly, the tumor spheroids derived from the MCW-OV-SL-3 cell line expressed high levels of c-Kit, PROM1, ZEB1, SNAI, VIM, and Twist1 compared to 2D monolayer cells. We also observed that the hyperactivation of ERK and PI3K/AKT signaling in these cancer cells resulted in resistance to cisplatin. In summary, the MCW-OV-SL3 endometrioid cell line is an excellent model to study the mechanism of cancer stemness and chemoresistance in endometrioid ovarian cancer.

16 May 2022 in Cancers
Verified
Journal Article
Open access
PDF file
Deepak ParasharDeepak Parashar
Deepak Parashar
AGANJALI GEETHADEVI
ANJALI GEETHADEVI
SMSonam Mittal
Sonam Mittal
LMLindsey A. McAlarnen
Lindsey A. McAlarnen
JGJasmine George
Jasmine George
PCPradeep Chaluvally-Raghavan
Pradeep Chaluvally-Raghavan
The authors would like to correct the author byline to include Dr

Verified
Journal Article
Open access
PDF file
Sudhir KumarSudhir Kumar
Sudhir Kumar
JCJagdish Chand
Jagdish Chand
PSPreeti Sharma
Preeti Sharma
SSSudhakar Singh
Sudhakar Singh
PKPukar Khanal
Pukar Khanal
SMSonam Mittal
Sonam Mittal
Metastasis remains the leading cause of cancer deaths, heavily influenced by aging-related biological processes. As global life expectancy increases, cancer incidence and progression complexity in older adults also rise, emphasizing the urgent need to understand how the aging tumor microenvironment (TME) promotes metastasis. This review explores the molecular and cellular mechanisms behind metastatic development in the aged TME, focusing on the combined impacts of cellular senescence, chronic inflammation (inflammaging), immune system decline, extracellular matrix (ECM) changes, and abnormal blood vessel growth. Aging causes an accumulation of senescent cells that secrete a range of cytokines, growth factors, and enzymes (SASPs), which remodel the ECM, making it stiffer and more degradable, and activate pro-metastatic pathways like TGF-β, STAT3, and MAPK, aiding processes like EMT and tumor invasion. Meanwhile, persistent low-grade inflammation attracts immunosuppressive cells, and immune decline hampers tumor surveillance, allowing cancer cells to evade immune detection. The aged TME also undergoes significant vascular and metabolic changes, such as abnormal angiogenesis and hypoxia, supporting the growth of more aggressive, treatment-resistant cancer clones and spreading metastases. These changes are driven by hallmarks of molecular aging, including telomere shortening, oxidative DNA damage, and epigenetic alterations, which lead to genetic instability and turn the aged stroma into fertile ground for metastasis. The review also discusses new therapeutic approaches, including senolytics, anti-inflammatory treatments, immune system rejuvenation, and metabolic strategies, highlighting the importance of age-specific models and precision medicine to enhance outcomes for the growing number of elderly cancer patients.

11 March 2024 in STAR Protocols
Verified
Journal Article
Open access
SMSonam Mittal
Sonam Mittal
Sudhir KumarSudhir Kumar
Sudhir Kumar
PGPrachi Gupta
Prachi Gupta
MSMona Singh
Mona Singh
PCPradeep Chaluvally-Raghavan
Pradeep Chaluvally-Raghavan
SPSunila Pradeep
Sunila Pradeep
Extracellular vesicles (EVs) play a crucial role in facilitating communication between cancer cells and their immediate or remote microenvironments, thereby promoting the extensive spread of cancer throughout the body. In this context, we present a protocol for the isolation of tumor cell-derived EVs followed by in vivo metastasis assessment in a murine ovarian cancer model. We describe steps for the isolation and characterization of EVs from ID8 cells, development of a metastatic mouse model, and sample preparation for flow cytometry. For complete details on the use and execution of this protocol, please refer to Gupta et al.1.